The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective cohort study on the safety and efficacy of cetuximab for metastatic colorectal cancer patients: The HGCSG0901 study—Analysis of cetuximab refractory.
Satoshi Yuki
No relevant relationships to disclose
Yoshito Komatsu
No relevant relationships to disclose
Yasuyuki Kawamoto
No relevant relationships to disclose
Yasushi Tsuji
No relevant relationships to disclose
Hirohito Naruse
No relevant relationships to disclose
Ayumu Hosokawa
No relevant relationships to disclose
Takaya Kusumi
No relevant relationships to disclose
Atsushi Ishiguro
No relevant relationships to disclose
Soh Saitoh
No relevant relationships to disclose
Yuh Sakata
No relevant relationships to disclose